O	O	0	4	Cell	Cell	B-NP	NN	O	3	NMOD	O
O	O	5	9	type	type	I-NP	NN	O	3	NMOD	O
O	O	10	21	specificity	specificity	I-NP	NN	O	6	NMOD	O
O	O	22	25	and	and	I-NP	CC	O	6	NMOD	O
O	O	26	36	activation	activation	I-NP	NN	O	6	NMOD	O
O	O	37	49	requirements	requirement	I-NP	NNS	O	0	ROOT	O
O	O	50	53	for	for	B-PP	IN	O	6	NMOD	O
T1	B-Protein	54	58	NFAT	NFAT	B-NP	NN	B-protein	21	NMOD	B-protein
T1	I-Protein	58	59	-	-	B-NP	HYPH	O	8	NMOD	O
T1	I-Protein	59	60	1	1	I-NP	CD	O	9	NMOD	O
O	O	61	62	(	(	O	(	O	19	DEP	O
O	O	62	69	nuclear	nuclear	B-NP	JJ	B-protein	19	DEP	B-protein
O	O	70	76	factor	factor	I-NP	NN	I-protein	12	PMOD	I-protein
O	O	77	79	of	of	B-PP	IN	I-protein	13	NMOD	I-protein
O	O	80	89	activated	activate	B-NP	VBN	I-protein	18	NMOD	I-protein
O	O	90	91	T	T	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	91	92	-	-	I-NP	HYPH	I-protein	18	NMOD	I-protein
O	O	92	97	cells	cell	I-NP	NNS	I-protein	14	PMOD	I-protein
O	O	97	98	)	)	O	)	O	8	NMOD	O
O	O	99	114	transcriptional	transcriptional	B-NP	JJ	O	21	NMOD	O
O	O	115	123	activity	activity	I-NP	NN	O	7	PMOD	O
O	O	124	134	determined	determine	B-VP	VBN	O	21	NMOD	O
O	O	135	137	by	by	B-PP	IN	O	22	VMOD	O
O	O	138	139	a	a	B-NP	DT	O	26	NMOD	O
O	O	140	143	new	new	I-NP	JJ	O	26	NMOD	O
O	O	144	150	method	method	I-NP	NN	O	23	PMOD	O
O	O	151	156	using	use	B-VP	VBG	O	26	NMOD	O
O	O	157	167	transgenic	transgenic	B-NP	JJ	O	29	NMOD	O
O	O	168	172	mice	mouse	I-NP	NNS	O	27	OBJ	O
O	O	173	175	to	to	B-VP	TO	O	31	VMOD	O
O	O	176	181	assay	assay	I-VP	VB	O	27	VMOD	O
O	O	182	197	transcriptional	transcriptional	B-NP	JJ	O	33	NMOD	O
O	O	198	206	activity	activity	I-NP	NN	O	31	OBJ	O
O	O	207	209	of	of	B-PP	IN	O	33	NMOD	O
O	O	210	212	an	an	B-NP	DT	O	38	NMOD	O
O	O	213	223	individual	individual	I-NP	JJ	O	38	NMOD	O
O	O	224	231	nuclear	nuclear	I-NP	JJ	B-protein	38	NMOD	B-protein
O	O	232	238	factor	factor	I-NP	NN	I-protein	34	PMOD	I-protein
O	O	238	239	.	.	O	.	O	6	P	O

O	O	241	248	Nuclear	Nuclear	B-NP	JJ	B-protein	2	NMOD	B-protein
O	O	249	255	factor	factor	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	256	258	of	of	B-PP	IN	I-protein	7	NMOD	I-protein
O	O	259	268	activated	activate	B-NP	VBN	I-protein	7	NMOD	I-protein
O	O	269	270	T	T	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	270	271	-	-	O	HYPH	I-protein	7	NMOD	I-protein
O	O	271	276	cells	cell	B-NP	NNS	I-protein	13	SUB	I-protein
O	O	277	278	(	(	O	(	O	12	DEP	O
T2	B-Protein	278	282	NFAT	NFAT	B-NP	NN	B-protein	11	NMOD	B-protein
T2	I-Protein	282	283	-	-	B-NP	HYPH	O	11	P	O
T2	I-Protein	283	284	1	1	I-NP	CD	O	12	DEP	O
O	O	284	285	)	)	O	)	O	7	NMOD	O
O	O	286	288	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	289	290	a	a	B-NP	DT	O	16	NMOD	O
O	O	291	304	transcription	transcription	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	305	311	factor	factor	I-NP	NN	I-protein	13	PRD	I-protein
O	O	312	317	which	which	B-NP	WDT	O	16	NMOD	O
O	O	318	320	is	be	B-VP	VBZ	O	17	SBAR	O
O	O	321	331	considered	consider	I-VP	VBN	O	18	VC	O
O	O	332	334	to	to	I-VP	TO	O	21	VMOD	O
O	O	335	337	be	be	I-VP	VB	O	19	VMOD	O
O	O	338	340	an	an	B-NP	DT	O	24	NMOD	O
O	O	341	350	important	important	I-NP	JJ	O	24	NMOD	O
O	O	351	360	regulator	regulator	I-NP	NN	O	21	PRD	O
O	O	361	363	in	in	B-PP	IN	O	24	NMOD	O
O	O	364	369	early	early	B-NP	JJ	O	30	NMOD	O
O	O	370	371	T	T	I-NP	NN	O	30	NMOD	O
O	O	371	372	-	-	B-NP	HYPH	O	30	NMOD	O
O	O	372	376	cell	cell	I-NP	NN	O	30	NMOD	O
O	O	377	387	activation	activation	I-NP	NN	O	25	PMOD	O
O	O	387	388	.	.	O	.	O	13	P	O

O	O	389	391	We	We	B-NP	PRP	O	2	SUB	O
O	O	392	396	have	have	B-VP	VBP	O	0	ROOT	O
O	O	397	406	developed	develop	I-VP	VBN	O	2	VC	O
O	O	407	408	a	a	B-NP	DT	O	5	NMOD	O
O	O	409	415	system	system	I-NP	NN	O	3	OBJ	O
O	O	416	418	to	to	B-VP	TO	O	7	VMOD	O
O	O	419	426	monitor	monitor	I-VP	VB	O	5	NMOD	O
O	O	427	430	the	the	B-NP	DT	O	10	NMOD	O
O	O	431	446	transcriptional	transcriptional	I-NP	JJ	O	10	NMOD	O
O	O	447	455	activity	activity	I-NP	NN	O	7	OBJ	O
O	O	456	458	of	of	B-PP	IN	O	10	NMOD	O
T3	B-Protein	459	463	NFAT	NFAT	B-NP	NN	B-protein	14	NMOD	B-protein
T3	I-Protein	463	464	-	-	B-NP	HYPH	O	14	P	O
T3	I-Protein	464	465	1	1	I-NP	CD	O	11	PMOD	O
O	O	466	468	at	at	B-PP	IN	O	14	NMOD	O
O	O	469	472	the	the	B-NP	DT	O	19	NMOD	O
O	O	473	479	single	single	I-NP	JJ	O	19	NMOD	O
O	O	480	484	cell	cell	I-NP	NN	O	19	NMOD	O
O	O	485	490	level	level	I-NP	NN	O	15	PMOD	O
O	O	491	493	in	in	B-PP	IN	O	10	NMOD	O
O	O	494	499	whole	whole	B-NP	JJ	O	22	NMOD	O
O	O	500	507	animals	animal	I-NP	NNS	O	20	PMOD	O
O	O	507	508	.	.	O	.	O	2	P	O

O	O	509	512	The	The	B-NP	DT	O	2	NMOD	O
O	O	513	519	system	system	I-NP	NN	O	3	SUB	O
O	O	520	522	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	523	528	based	base	I-VP	VBN	O	3	VC	O
O	O	529	531	on	on	B-PP	IN	O	4	VMOD	O
O	O	532	535	the	the	B-NP	DT	O	7	NMOD	O
O	O	536	539	use	use	I-NP	NN	O	5	PMOD	O
O	O	540	542	of	of	B-PP	IN	O	7	NMOD	O
O	O	543	545	an	an	B-NP	DT	O	11	NMOD	O
O	O	546	558	oligomerized	oligomerized	I-NP	JJ	O	11	NMOD	O
T4	B-Protein	559	563	NFAT	NFAT	I-NP	NN	B-protein	15	NMOD	B-protein
T4	I-Protein	563	564	-	-	B-NP	HYPH	O	15	NMOD	O
T4	I-Protein	564	565	1	1	I-NP	CD	O	15	NMOD	O
T13	B-Entity	566	573	binding	binding	I-NP	NN	O	15	NMOD	O
T13	I-Entity	574	579	motif	motif	I-NP	NN	O	8	PMOD	O
O	O	580	584	that	that	B-NP	WDT	O	15	NMOD	O
O	O	585	592	directs	direct	B-VP	VBZ	O	16	SBAR	O
O	O	593	606	transcription	transcription	B-NP	NN	O	17	OBJ	O
O	O	607	609	of	of	B-PP	IN	O	18	NMOD	O
O	O	610	614	SV40	SV40	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	615	616	T	T	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	616	617	-	-	I-NP	HYPH	I-protein	23	NMOD	I-protein
O	O	617	624	antigen	antigen	I-NP	NN	I-protein	19	PMOD	I-protein
O	O	625	627	in	in	B-PP	IN	O	18	NMOD	O
O	O	628	638	transgenic	transgenic	B-NP	JJ	O	26	NMOD	O
O	O	639	643	mice	mouse	I-NP	NNS	O	24	PMOD	O
O	O	643	644	.	.	O	.	O	3	P	O

O	O	645	649	This	This	B-NP	DT	O	2	NMOD	O
O	O	650	656	report	report	I-NP	NN	O	3	SUB	O
O	O	657	667	represents	represent	B-VP	VBZ	O	0	ROOT	O
O	O	668	671	the	the	B-NP	DT	O	6	NMOD	O
O	O	672	677	first	first	I-NP	JJ	O	6	NMOD	O
O	O	678	691	demonstration	demonstration	I-NP	NN	O	3	OBJ	O
O	O	692	696	that	that	B-NP	IN	O	6	NMOD	O
O	O	697	698	a	a	B-NP	DT	O	12	NMOD	O
T14	B-Entity	699	711	multimerized	multimerized	I-NP	JJ	B-DNA	12	NMOD	B-DNA
T14	I-Entity	712	717	short	short	I-NP	JJ	I-DNA	12	NMOD	I-DNA
T14	I-Entity	718	725	binding	binding	I-NP	NN	I-DNA	12	NMOD	I-DNA
T14	I-Entity	726	731	motif	motif	I-NP	NN	I-DNA	13	SUB	I-DNA
O	O	732	735	can	can	B-VP	MD	O	7	SBAR	O
O	O	736	744	function	function	I-VP	VB	O	13	VC	O
O	O	745	758	appropriately	appropriately	B-ADVP	RB	O	14	VMOD	O
O	O	759	761	in	in	B-PP	IN	O	14	VMOD	O
O	O	762	772	transgenic	transgenic	B-NP	JJ	O	18	NMOD	O
O	O	773	777	mice	mouse	I-NP	NNS	O	16	PMOD	O
O	O	777	778	.	.	O	.	O	3	P	O

T5	B-Protein	779	783	NFAT	NFAT	B-NP	NN	B-protein	4	NMOD	B-protein
T5	I-Protein	783	784	-	-	B-NP	HYPH	O	4	NMOD	O
T5	I-Protein	784	785	1	1	I-NP	CD	O	4	NMOD	O
O	O	786	794	activity	activity	I-NP	NN	O	5	SUB	O
O	O	795	798	had	have	B-VP	VBD	O	0	ROOT	O
O	O	799	809	previously	previously	I-VP	RB	O	5	VMOD	O
O	O	810	814	been	be	I-VP	VBN	O	5	VC	O
O	O	815	822	thought	think	I-VP	VBN	O	7	VC	O
O	O	823	825	to	to	I-VP	TO	O	10	VMOD	O
O	O	826	828	be	be	I-VP	VB	O	8	VMOD	O
O	O	829	837	confined	confine	I-VP	VBN	O	10	VC	O
O	O	838	840	to	to	B-PP	TO	O	11	VMOD	O
O	O	841	850	activated	activate	B-NP	VBN	O	16	NMOD	O
O	O	851	852	T	T	I-NP	NN	O	16	NMOD	O
O	O	852	853	-	-	O	HYPH	O	16	NMOD	O
O	O	853	864	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	12	PMOD	B-cell_type
O	O	865	869	upon	upon	B-PP	IN	O	11	VMOD	O
O	O	870	877	release	release	B-NP	NN	O	17	PMOD	O
O	O	878	880	of	of	B-PP	IN	O	18	NMOD	O
O	O	881	894	intracellular	intracellular	B-NP	JJ	O	21	NMOD	O
O	O	895	902	calcium	calcium	I-NP	NN	O	19	PMOD	O
O	O	902	903	.	.	O	.	O	5	P	O

O	O	904	906	By	By	B-PP	IN	O	14	VMOD	O
O	O	907	916	targeting	target	B-VP	VBG	O	1	PMOD	O
T6	B-Protein	917	921	NFAT	NFAT	B-NP	NN	B-protein	9	NMOD	B-protein
T6	I-Protein	921	922	-	-	B-NP	HYPH	O	9	NMOD	O
T6	I-Protein	922	923	1	1	I-NP	CD	O	7	AMOD	O
O	O	923	924	-	-	I-NP	HYPH	O	7	AMOD	O
O	O	924	933	dependent	dependent	I-NP	JJ	O	9	NMOD	O
O	O	934	938	gene	gene	I-NP	NN	O	9	NMOD	O
O	O	939	949	expression	expression	I-NP	NN	O	2	OBJ	O
O	O	950	952	in	in	B-PP	IN	O	9	NMOD	O
O	O	953	963	transgenic	transgenic	B-NP	JJ	O	12	NMOD	O
O	O	964	968	mice	mouse	I-NP	NNS	O	10	PMOD	O
O	O	969	971	we	we	B-NP	PRP	O	14	SUB	O
O	O	972	982	discovered	discover	B-VP	VBD	O	0	ROOT	O
O	O	983	986	new	new	B-NP	JJ	O	16	NMOD	O
O	O	987	992	sites	site	I-NP	NNS	O	14	OBJ	O
O	O	993	995	of	of	B-PP	IN	O	16	NMOD	O
T7	B-Protein	996	1000	NFAT	NFAT	B-NP	NN	B-protein	21	NMOD	B-protein
T7	I-Protein	1000	1001	-	-	B-NP	HYPH	O	21	NMOD	O
T7	I-Protein	1001	1002	1	1	I-NP	CD	O	21	NMOD	O
O	O	1003	1011	activity	activity	I-NP	NN	O	17	PMOD	O
O	O	1011	1012	.	.	O	.	O	14	P	O

O	O	1013	1020	Besides	Besides	B-PP	IN	O	10	VMOD	O
O	O	1021	1023	in	in	B-PP	IN	O	1	PMOD	O
O	O	1024	1025	T	T	B-NP	NN	B-cell_type	5	NMOD	B-cell_type
O	O	1025	1026	-	-	B-NP	HYPH	I-cell_type	5	NMOD	I-cell_type
O	O	1026	1037	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
T8	B-Protein	1038	1042	NFAT	NFAT	I-NP	NN	B-protein	9	NMOD	B-protein
T8	I-Protein	1042	1043	-	-	B-NP	HYPH	O	9	NMOD	O
T8	I-Protein	1043	1044	1	1	I-NP	CD	O	9	NMOD	O
O	O	1045	1053	activity	activity	I-NP	NN	O	10	SUB	O
O	O	1054	1059	could	could	B-VP	MD	O	0	ROOT	O
O	O	1060	1064	also	also	I-VP	RB	O	10	VMOD	O
O	O	1065	1067	be	be	I-VP	VB	O	10	VC	O
O	O	1068	1075	induced	induce	I-VP	VBN	O	12	VC	O
O	O	1076	1078	in	in	B-PP	IN	O	13	VMOD	O
O	O	1079	1080	T	T	B-NP	NN	B-cell_type	17	NMOD	B-cell_type
O	O	1080	1081	-	-	B-NP	HYPH	I-cell_type	17	P	I-cell_type
O	O	1081	1091	lymphocyte	lymphocyte	I-NP	NN	I-cell_type	21	NMOD	I-cell_type
O	O	1091	1092	-	-	B-NP	HYPH	O	21	NMOD	O
O	O	1092	1100	depleted	deplete	I-NP	VBN	O	21	NMOD	O
O	O	1101	1107	spleen	spleen	I-NP	NN	B-cell_type	21	NMOD	B-cell_type
O	O	1108	1113	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	1114	1117	and	and	O	CC	O	21	NMOD	O
O	O	1118	1126	purified	purify	B-NP	VBN	B-protein	24	NMOD	B-protein
O	O	1127	1128	B	B	I-NP	NN	I-protein	25	NMOD	I-protein
O	O	1128	1129	-	-	O	HYPH	O	28	VMOD	O
O	O	1129	1140	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	25	PRD	B-cell_type
O	O	1141	1144	and	and	O	CC	O	28	VMOD	O
O	O	1145	1153	requires	require	B-VP	VBZ	O	22	SBAR	O
O	O	1154	1160	agents	agent	B-NP	NNS	O	28	OBJ	O
O	O	1161	1165	that	that	B-SBAR	IN	O	29	NMOD	O
O	O	1166	1170	both	both	O	CC	O	32	VMOD	O
O	O	1171	1178	release	release	B-VP	VB	O	30	SBAR	O
O	O	1179	1192	intracellular	intracellular	B-NP	JJ	O	34	NMOD	O
O	O	1193	1200	calcium	calcium	I-NP	NN	O	32	OBJ	O
O	O	1201	1204	and	and	O	CC	O	32	VMOD	O
O	O	1205	1213	activate	activate	B-VP	VBP	O	32	VMOD	O
O	O	1214	1221	protein	protein	B-NP	NN	B-protein	39	NMOD	B-protein
O	O	1222	1228	kinase	kinase	I-NP	NN	I-protein	39	NMOD	I-protein
O	O	1229	1230	C	C	I-NP	NN	I-protein	36	OBJ	I-protein
O	O	1230	1231	.	.	O	.	O	10	P	O

O	O	1232	1233	A	A	B-NP	DT	O	2	NMOD	O
O	O	1234	1244	difference	difference	I-NP	NN	O	24	SUB	O
O	O	1245	1247	in	in	B-PP	IN	O	2	NMOD	O
O	O	1248	1251	the	the	B-NP	DT	O	6	NMOD	O
O	O	1252	1256	time	time	I-NP	NN	O	6	NMOD	O
O	O	1257	1263	course	course	I-NP	NN	O	3	PMOD	O
O	O	1264	1266	of	of	B-PP	IN	O	6	NMOD	O
O	O	1267	1277	appearance	appearance	B-NP	NN	O	7	PMOD	O
O	O	1278	1280	of	of	B-PP	IN	O	8	NMOD	O
T9	B-Protein	1281	1285	NFAT	NFAT	B-NP	NN	B-protein	13	NMOD	B-protein
T9	I-Protein	1285	1286	-	-	B-NP	HYPH	O	13	NMOD	O
T9	I-Protein	1286	1287	1	1	I-NP	CD	O	13	NMOD	O
O	O	1288	1296	activity	activity	I-NP	NN	O	9	PMOD	O
O	O	1297	1304	between	between	B-PP	IN	O	13	NMOD	O
O	O	1305	1306	T	T	B-NP	NN	B-cell_type	17	NMOD	B-cell_type
O	O	1306	1307	-	-	I-NP	HYPH	I-cell_type	17	NMOD	I-cell_type
O	O	1307	1318	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	23	NMOD	I-cell_type
O	O	1319	1322	and	and	O	CC	O	23	NMOD	O
O	O	1323	1326	non	non	B-NP	AFX	O	23	NMOD	O
O	O	1326	1327	-	-	I-NP	HYPH	B-cell_type	23	NMOD	B-cell_type
O	O	1327	1328	T	T	I-NP	NN	I-cell_type	23	NMOD	I-cell_type
O	O	1328	1329	-	-	I-NP	HYPH	I-cell_type	23	NMOD	I-cell_type
O	O	1329	1340	lymphocytes	lymphocyte	B-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	1341	1344	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1345	1353	revealed	reveal	I-VP	VBN	O	24	VC	O
O	O	1353	1354	.	.	O	.	O	24	P	O

O	O	1355	1367	Constitutive	Constitutive	B-NP	JJ	O	2	NMOD	O
O	O	1368	1378	expression	expression	I-NP	NN	O	3	SUB	O
O	O	1379	1382	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1383	1391	observed	observe	I-VP	VBN	O	3	VC	O
O	O	1392	1394	in	in	B-PP	IN	O	4	VMOD	O
O	O	1395	1396	a	a	B-NP	DT	O	8	NMOD	O
O	O	1397	1402	small	small	I-NP	JJ	O	8	NMOD	O
O	O	1403	1413	population	population	I-NP	NN	O	16	NMOD	O
O	O	1414	1416	of	of	B-PP	IN	O	8	NMOD	O
O	O	1417	1422	cells	cell	B-NP	NNS	O	9	PMOD	O
O	O	1423	1425	in	in	B-PP	IN	O	8	NMOD	O
O	O	1426	1429	the	the	B-NP	DT	O	13	NMOD	O
O	O	1430	1436	dermis	dermis	I-NP	NN	O	11	PMOD	O
O	O	1437	1440	and	and	O	CC	O	16	NMOD	O
O	O	1441	1445	some	some	B-NP	DT	O	16	NMOD	O
O	O	1446	1450	mice	mouse	I-NP	NNS	O	5	PMOD	O
O	O	1451	1455	have	have	B-VP	VBP	O	3	VMOD	O
O	O	1456	1465	developed	develop	I-VP	VBN	O	17	VC	O
O	O	1466	1470	skin	skin	B-NP	NN	O	20	NMOD	O
O	O	1471	1478	lesions	lesion	I-NP	NNS	O	18	OBJ	O
O	O	1478	1479	.	.	O	.	O	3	P	O

O	O	1480	1493	Interestingly	Interestingly	B-ADVP	RB	O	14	VMOD	O
O	O	1493	1494	,	,	O	,	O	14	P	O
O	O	1495	1498	the	the	B-NP	DT	O	5	NMOD	O
O	O	1499	1505	tissue	tissue	I-NP	NN	O	5	NMOD	O
O	O	1506	1513	pattern	pattern	I-NP	NN	O	14	SUB	O
O	O	1514	1516	of	of	B-PP	IN	O	5	NMOD	O
O	O	1517	1527	expression	expression	B-NP	NN	O	6	PMOD	O
O	O	1528	1530	of	of	B-PP	IN	O	7	NMOD	O
O	O	1531	1534	the	the	B-NP	DT	O	13	NMOD	O
T10	B-Protein	1535	1539	NFAT	NFAT	I-NP	NN	B-protein	13	NMOD	B-protein
T10	I-Protein	1539	1540	-	-	B-NP	HYPH	O	13	NMOD	O
T10	I-Protein	1540	1541	1	1	I-NP	CD	O	13	NMOD	O
O	O	1542	1550	activity	activity	I-NP	NN	O	8	PMOD	O
O	O	1551	1560	resembles	resemble	B-VP	VBZ	O	0	ROOT	O
O	O	1561	1564	the	the	B-NP	DT	O	17	NMOD	O
O	O	1565	1575	expression	expression	I-NP	NN	O	17	NMOD	O
O	O	1576	1583	pattern	pattern	I-NP	NN	O	14	OBJ	O
O	O	1584	1593	described	describe	B-VP	VBN	O	17	NMOD	O
O	O	1594	1597	for	for	B-PP	IN	O	18	VMOD	O
T15	B-Entity	1598	1601	HIV	HIV	B-NP	NN	B-DNA	26	NMOD	B-DNA
T15	I-Entity	1601	1602	-	-	I-NP	HYPH	I-DNA	26	NMOD	I-DNA
T15	I-Entity	1602	1605	LTR	LTR	I-NP	NN	I-DNA	26	NMOD	I-DNA
T15	I-Entity	1605	1606	/	/	I-NP	SYM	O	26	NMOD	O
T15	I-Entity	1606	1609	tat	tat	I-NP	NN	O	26	NMOD	O
O	O	1610	1620	transgenic	transgenic	I-NP	JJ	O	26	NMOD	O
O	O	1621	1625	mice	mouse	I-NP	NNS	O	19	PMOD	O
O	O	1626	1627	(	(	O	(	O	68	DEP	O
O	O	1627	1632	Vogel	Vogel	B-NP	NNP	O	33	NMOD	O
O	O	1632	1633	,	,	O	,	O	33	P	O
O	O	1634	1635	J	J	B-NP	NNP	O	33	NMOD	O
O	O	1635	1636	.	.	O	.	O	30	P	O
O	O	1636	1637	,	,	O	,	O	33	P	O
O	O	1638	1646	Hinrichs	Hinrichs	B-NP	NNP	O	35	NMOD	O
O	O	1646	1647	,	,	O	,	O	35	P	O
O	O	1648	1649	S	S	B-NP	NNP	O	37	NMOD	O
O	O	1649	1650	.	.	I-NP	.	O	37	NMOD	O
O	O	1651	1652	H	H	I-NP	NNP	O	38	SUB	O
O	O	1652	1653	.	.	B-VP	VBD	O	67	VMOD	O
O	O	1653	1654	,	,	O	,	O	67	P	O
O	O	1655	1663	Reynolds	Reynolds	B-NP	NNP	O	67	NMOD	O
O	O	1663	1664	,	,	O	,	O	67	P	O
O	O	1665	1666	R	R	B-NP	NNP	O	45	NMOD	O
O	O	1666	1667	.	.	I-NP	.	O	45	P	O
O	O	1668	1669	K	K	I-NP	NNP	O	45	NMOD	O
O	O	1669	1670	.	.	I-NP	NNP	O	67	NMOD	O
O	O	1670	1671	,	,	O	,	O	67	P	O
O	O	1672	1677	Luciw	Luciw	B-NP	NNP	O	49	NMOD	O
O	O	1677	1678	,	,	O	,	O	49	P	O
O	O	1679	1680	P	P	B-NP	NNP	O	52	NMOD	O
O	O	1680	1681	.	.	I-NP	.	O	52	NMOD	O
O	O	1682	1683	A	A	I-NP	NNP	O	52	NMOD	O
O	O	1683	1684	.	.	I-NP	NN	O	67	NMOD	O
O	O	1684	1685	,	,	O	,	O	67	P	O
O	O	1686	1689	and	and	O	CC	O	57	NMOD	O
O	O	1690	1693	Jay	Jay	B-NP	NNP	O	57	NMOD	O
O	O	1693	1694	,	,	O	,	O	57	P	O
O	O	1695	1696	G	G	B-NP	NNP	O	67	NMOD	O
O	O	1696	1697	.	.	O	.	O	57	P	O
O	O	1698	1699	(	(	O	(	O	57	NMOD	O
O	O	1699	1703	1988	1988	B-NP	CD	O	57	NMOD	O
O	O	1703	1704	)	)	O	)	O	57	NMOD	O
O	O	1705	1711	Nature	Nature	B-NP	NNP	O	67	NMOD	O
O	O	1712	1715	335	335	I-NP	CD	O	62	NMOD	O
O	O	1715	1716	,	,	I-NP	,	O	67	P	O
O	O	1717	1720	606	606	I-NP	CD	O	67	NMOD	O
O	O	1720	1721	-	-	I-NP	HYPH	O	67	P	O
O	O	1721	1724	611	611	I-NP	CD	O	68	DEP	O
O	O	1724	1725	)	)	O	)	O	14	VMOD	O
O	O	1725	1726	.	.	O	.	O	14	P	O

O	O	1727	1731	This	This	B-NP	DT	O	2	NMOD	O
O	O	1732	1742	similarity	similarity	I-NP	NN	O	7	NMOD	O
O	O	1743	1745	in	in	B-PP	IN	O	2	NMOD	O
O	O	1746	1756	expression	expression	B-NP	NN	O	3	PMOD	O
O	O	1757	1760	and	and	O	CC	O	7	NMOD	O
O	O	1761	1764	the	the	B-NP	DT	O	7	NMOD	O
O	O	1765	1769	fact	fact	I-NP	NN	O	23	SUB	O
O	O	1770	1774	that	that	B-SBAR	IN	O	7	NMOD	O
T11	B-Protein	1775	1779	NFAT	NFAT	B-NP	NN	B-protein	10	NMOD	B-protein
T11	I-Protein	1779	1780	-	-	B-NP	HYPH	O	12	SUB	O
T11	I-Protein	1780	1781	1	1	I-NP	CD	O	10	NMOD	O
O	O	1782	1785	has	have	B-VP	VBZ	O	8	SBAR	O
O	O	1786	1790	been	be	I-VP	VBN	O	12	VC	O
O	O	1791	1796	shown	show	I-VP	VBN	O	13	VC	O
O	O	1797	1799	to	to	I-VP	TO	O	16	VMOD	O
O	O	1800	1804	bind	bind	I-VP	VB	O	14	VMOD	O
T16	B-Entity	1805	1815	functional	functional	B-NP	JJ	B-DNA	18	NMOD	B-DNA
T16	I-Entity	1816	1825	sequences	sequence	I-NP	NNS	I-DNA	16	OBJ	I-DNA
O	O	1826	1828	in	in	B-PP	IN	O	18	NMOD	O
T17	B-Entity	1829	1832	HIV	HIV	B-NP	NN	O	22	NMOD	O
T17	I-Entity	1832	1833	-	-	B-NP	HYPH	O	22	NMOD	O
T17	I-Entity	1833	1836	LTR	LTR	I-NP	NN	B-DNA	19	PMOD	B-DNA
O	O	1837	1844	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1845	1846	a	a	B-NP	DT	O	25	NMOD	O
O	O	1847	1851	role	role	I-NP	NN	O	23	OBJ	O
O	O	1852	1855	for	for	B-PP	IN	O	25	NMOD	O
T12	B-Protein	1856	1860	NFAT	NFAT	B-NP	NN	B-protein	28	NMOD	B-protein
T12	I-Protein	1860	1861	-	-	B-NP	HYPH	O	26	PMOD	O
T12	I-Protein	1861	1862	1	1	I-NP	CD	O	28	NMOD	O
O	O	1863	1865	in	in	B-PP	IN	O	25	NMOD	O
O	O	1866	1872	dermal	dermal	B-NP	JJ	O	32	NMOD	O
O	O	1873	1883	activation	activation	I-NP	NN	O	30	PMOD	O
O	O	1884	1886	of	of	B-PP	IN	O	32	NMOD	O
O	O	1887	1890	the	the	B-NP	DT	O	37	NMOD	O
T18	B-Entity	1891	1894	HIV	HIV	I-NP	NN	B-DNA	37	NMOD	B-DNA
T18	I-Entity	1894	1895	-	-	B-NP	HYPH	I-DNA	37	NMOD	I-DNA
T18	I-Entity	1895	1898	LTR	LTR	I-NP	NN	I-DNA	33	PMOD	I-DNA
O	O	1898	1899	.	.	O	.	O	23	P	O
